Data reflect disparities in use of next-generation sequencing for lung cancer

Healio: Debora Bruno, assistant professor of medicine at the School of Medicine and member of the Population and Cancer Prevention Program at Case Comprehensive Cancer Center, lended insight into her recent research that showed that only one in four Black patients with advanced or metastatic non-small cell lung cancer underwent next-generation sequencing before first-line therapy compared with one in three white patients.